NYU Langone
- Adult & Family Medicine
- Oncology and Hematology
- Neurology & Neurosurgery
- Gastroenterology
-
Cardiovascular
Cardiac Amyloidosis: Diagnosis and Novel Therapeutics in 2024 Advanced Heart Failure Cases and Controversies Invasive Cardiology Update for Practicing Health Care Professionals 2023 Unique Topics in Adult Congenital Heart Disease Management Decisions in Hypertrophic Cardiomyopathy Imaging in Adult Congenital Heart Disease Cases and Controversies in Heart Failure 2022 Venous Thrombosis Update 2022
- Pulmonology
- Dermatology
- Endocrinology
- Rheumatology
- Events
Playback speed
10 seconds
ASCO® 2024 Insights: "KEYNOTE-942 Trial - 3-Year Update on mRNA-4157 & Pembro in Resected Melanoma"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Jeffrey Weber
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Jeffrey Weber
226 views
June 12, 2024
Chapters
KEYNOTE-942 Trial & mRNA-4157 Overview
00:00
Trial Design & Patient Eligibility
02:49
3-Year Treatment Results & Survival Data
04:22
Safety Profile & Biomarker Analyses
06:56
Comments 0
Login to view comments.
Click here to Login
Videos
Case Presentation on HER2+ Breast Cancer: Adapting Patient Care to a…
NYU Langone
D. Marks
259 views
The Great Debate: Is Neoadjuvant Therapy Really Better Than Adjuvant…
NYU Langone
J. Weber
344 views